Visiodent (SDT.PA) Stock Price

Visiodent Price

Delisted
3.00EUR
Last traded price

Revenue at Visiodent has contracted by 1.0% per year over the past 19 years to 9.09 M EUR. Earnings per share have declined at 0.6% per year over the last 18 years. For Visiodent, the net margin of 6.8% is broadly stable versus 6.7% a few years ago. At today's price the dividend yield works out to roughly 3.67%. The payout ratio is around 97% of earnings.

Visiodent stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Visiodent over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Visiodent stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Visiodent's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Visiodent Stock Price History
DateVisiodent Price
Access this data via the Eulerpool API

Visiodent Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2013
7.17 M EUR
-450,000.00 EUR
-530,000.00 EUR
Jan 1, 2014
7.22 M EUR
669,780.00 EUR
528,560.00 EUR
Jan 1, 2015
6.73 M EUR
655,370.00 EUR
566,830.00 EUR
Jan 1, 2016
7.19 M EUR
633,080.00 EUR
481,960.00 EUR
Jan 1, 2017
7.31 M EUR
440,000.00 EUR
400,000.00 EUR
Jan 1, 2018
7.37 M EUR
340,000.00 EUR
550,000.00 EUR
Jan 1, 2019
8.26 M EUR
310,000.00 EUR
510,000.00 EUR
Jan 1, 2020
9.09 M EUR
370,000.00 EUR
620,000.00 EUR

Visiodent Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 24, 2026, 8:23 AM
 
REVENUEM EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM EUR
EBITk EUR
EBIT MARGIN%
NET INCOMEk EUR
SHARESM
2005200620072008200920102011201220132014201520162017201820192020
9.009.009.009.008.005.006.006.007.007.006.007.007.007.008.009.00
-11.11-37.5020.0016.67-14.2916.6714.2912.50
44.4455.5644.4455.5650.0060.0050.0050.0042.8642.8650.0042.8642.8642.8650.0044.44
4.005.004.005.004.003.003.003.003.003.003.003.003.003.004.004.00
1,000.00
11.11
4.274.214.274.204.204.204.204.204.204.504.504.504.504.504.504.50
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Visiodent generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Visiodent retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Visiodent's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Visiodent has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Visiodent's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Visiodent stock margins

The Visiodent margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Visiodent. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Visiodent.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2013
55.51 %
-6.28 %
-7.39 %
Jan 1, 2014
54.88 %
9.28 %
7.32 %
Jan 1, 2015
56.56 %
9.74 %
8.42 %
Jan 1, 2016
52.06 %
8.80 %
6.70 %
Jan 1, 2017
50.89 %
6.02 %
5.47 %
Jan 1, 2018
53.73 %
4.61 %
7.46 %
Jan 1, 2019
53.87 %
3.75 %
6.17 %
Jan 1, 2020
51.71 %
4.07 %
6.82 %

Visiodent Stock Revenue, EBIT, Earnings per Share

The Visiodent earnings per share therefore indicates how much revenue Visiodent has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2013
1.71 EUR
-0.11 EUR
-0.13 EUR
Jan 1, 2014
1.60 EUR
0.15 EUR
0.12 EUR
Jan 1, 2015
1.49 EUR
0.15 EUR
0.13 EUR
Jan 1, 2016
1.60 EUR
0.14 EUR
0.11 EUR
Jan 1, 2017
1.62 EUR
0.10 EUR
0.09 EUR
Jan 1, 2018
1.64 EUR
0.08 EUR
0.12 EUR
Jan 1, 2019
1.84 EUR
0.07 EUR
0.11 EUR
Jan 1, 2020
2.02 EUR
0.08 EUR
0.14 EUR

Visiodent business model & stock analysis

Visiodent SA is a French company specializing in the development and sale of dental products for over 60 years. It is headquartered in Paris and operates worldwide. Visiodent SA is a brand of the publicly traded company Acteon Group SA, listed on Euronext Paris since 1993.

Visiodent SWOT Analysis

Strengths

Visiodent SA possesses several strengths that contribute to its success and market position. These strengths include:

  • Strong brand reputation and recognition in the dental industry
  • Advanced technological capabilities in dental imaging and software solutions
  • Extensive product portfolio catering to a wide range of dental professionals
  • Established distribution network with global reach
  • Industry-leading research and development capabilities

Weaknesses

Despite its strengths, Visiodent SA also faces certain weaknesses that could hinder its growth and competitiveness. These weaknesses include:

  • Reliance on a limited number of key customers for substantial revenue
  • Higher pricing compared to some competitors
  • Limited market share in certain geographic regions
  • Slow response to market trends and changing customer needs
  • Lack of diversification in product offerings

Opportunities

Visiodent SA can capitalize on various opportunities to further expand its business and improve market position. These opportunities include:

  • Growing demand for advanced dental imaging technologies globally
  • Emerging markets offering new customer segments and untapped potential
  • Increasing focus on preventive dental care and digital dentistry
  • Potential for strategic partnerships or acquisitions to enhance product offerings
  • Advancements in artificial intelligence and data analytics for dental diagnostics

Threats

Visiodent SA is exposed to various threats that could impact its business operations and market performance. These threats include:

  • Intense competition from both established dental technology companies and new entrants
  • Regulatory changes and compliance requirements affecting product development and sales
  • Economic downturns impacting overall dental industry spending
  • Rapid technological advancements making existing products obsolete
  • Increasing price pressure from cost-conscious dental professionals

Visiodent Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Visiodent historical P/E ratio, EBIT multiple, and P/S ratio

Visiodent annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Visiodent shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2013
4.20 M Stocks
Jan 1, 2014
4.50 M Stocks
Jan 1, 2015
4.50 M Stocks
Jan 1, 2016
4.50 M Stocks
Jan 1, 2017
4.50 M Stocks
Jan 1, 2018
4.50 M Stocks
Jan 1, 2019
4.50 M Stocks
Jan 1, 2020
4.50 M Stocks

Visiodent stock splits

In Visiodent's history, there have been no stock splits.

Visiodent Dividend History

9 years of dividend payments

YearAnnual DividendYoY ChangePayments
20210.10EUR 9.1%
20190.11EUR 0.0%
20180.11EUR 0.0%
20170.11EUR 0.0%
20160.11EUR 0.0%
20150.11EUR 120.0%
20090.05EUR 64.3%
20080.14EUR 97.2%
20004.95EUR

Visiodent dividend payout ratio

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2013
103.60 %
Jan 1, 2014
103.60 %
Jan 1, 2015
87.41 %
Jan 1, 2016
102.80 %
Jan 1, 2017
123.75 %
Jan 1, 2018
90.00 %
Jan 1, 2019
97.06 %
Jan 1, 2020
103.60 %
Price targets and forecasts for Visiodent are not yet available.

Visiodent shareholder structure

% Name
95.29021%
Groupe Visiodent SAS
Groupe Visiodent SAS
6.67408%
Ohnona Family
Ohnona Family

Visiodent Executives and Management Board

JS

Jacques Sebag

Deputy Chief Executive Officer, Director

Compensation399,135.00 EUR
MO

Michel Ohnona

Chairman of the Board, Chief Executive Officer

Compensation264,398.00 EUR
CO

Christiane Ohnona

Director

Compensation43,422.00 EUR
AS

Annie Sebag

Director

Compensation43,422.00 EUR
SP

Sarah Peyrelevade

Director

Frequently asked questions about Visiodent

The business model of Visiodent SA centers around the provision of innovative dental imaging solutions. As a leading company in the dental industry, Visiodent SA incorporates advanced technologies and expertise to develop and manufacture high-quality dental imaging devices. By offering an extensive range of digital imaging solutions, Visiodent SA aims to enhance dental professionals' capabilities in diagnosing and treating patients effectively. With a focus on research and development, Visiodent SA continuously strives to stay at the forefront of dental imaging technology, providing cutting-edge products that contribute to improved dental care worldwide.

All fundamentals and in-depth analysis of Visiodent

Our stock analysis for Visiodent stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Visiodent. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.